VIMTALABSVIMTALABS Forensic Risk Analysis

Healthcare Research Analytics & Technology
Risk ClassStable
Market CapN/A
Primary DriverEarnings Quality
Flagium AI Risk Score
Stable structural profile. Financial profile appears resilient.
5 / 100
+5 QoQ
Early Deterioration
Sentinel Insight

Financial profile remains stable for now. Weakness is detected in profitability and earnings quality. No immediate concerns are visible. Risk is increasing at a faster pace.

0.0th %ile (Sector)Accel: +1 Qtrs
Updated2026-06-02
Market View
₹469.7▲1.63%
PeriodQ4 FY26

Score Waterfall
Absolute contribution points of each forensic pillar to the final risk score. Derived from: Sector Baseline + Active Penalties - Mitigation Buffers.

Earnings Quality
+4.8 pts
Final Composite Risk5 / 100

Investment Risk Thesis

Historical Trend

Current risk score has risen from 0 → 5 over 12 quarters.

Expected Direction
⚠ Watch
Primary Deterioration Drivers
  • Inventory Stress
  • Operating Leverage Stress
  • Capex Efficiency Stress
What to Watch Next Quarter
  • Operating profit margins
  • Inventory turnover
  • Debt growth

Active Risk Objects (4)

CriticalHigh
Capex Efficiency Stress
📊 Earnings QualityAnnualActive for 1 Years
More Detail
Impact Weight8/15
MomentumDecaying
Last SignalQ2 FY2024
Aggressive Capex (55.8%) amidst slow revenue growth (-6.4%).

"Earnings quality is stabilizing. The reliance on non-operational items is receding."

Profit Collapse
📊 Earnings QualityQuarterlyActive for 1 Qtrs
More Detail
Impact Weight8/15
MomentumDecaying
Last SignalQ2 FY2024
VIMTALABS: Net Profit collapsed by 52.1% from FY2023 Q2 to FY2024 Q2.

"Earnings quality is stabilizing. The reliance on non-operational items is receding."

Inventory Stress
📊 Earnings QualityAnnualActive for 1 Years
More Detail
Impact Weight15/15
MomentumDecaying
Last SignalQ2 FY2024
Inventory growth (32.7%) significantly outpaced revenue growth (-6.4%).

"Inventory overhang is clearing. Stock levels are normalizing as sales momentum returns."

Operating Leverage Stress
📊 Earnings QualityAnnualActive for 1 Years
More Detail
Impact Weight10/15
MomentumAccelerating
Last SignalQ4 FY2026
Expenses are consistently growing faster than revenues, creating operational pressure.

"Debt levels are creeping up. Monitor for signs of excessive borrowing for non-core activities."

Risk Trajectory
Historical 12-quarter risk trend (Q-11 to Q0) followed by a 2-quarter predictive funnel (Q+1, Q+2).
Loading Chart
Resilience Matrix
Diagnostic benchmarking comparing structural sensitivity and risk buffers against sector medians.
MetricValuevs SectorSignal
Volatility (σ)6.829.14✅ RESILIENT
Sensitivity (ε_s)11.00✅ RESILIENT
Escalation Prob.5%5%✅ NEUTRAL
Safety Buffer+61.0+53.0✅ RESILIENT
Forensic Benchmark Context: Healthcare Research Analytics & Technology (n=5 peers)

Correlation Analysis
Visualizing the relationship between stock price movement and structural risk objects.

Loading Chart
Share Price
Risk Score (0-100)
Market Performance
₹469.7(+1.63%)
1M Divergence+0.48%
1 Week+1.59%
1 Month+2.75%
6 Months-22.73%
1 Year-2.7%
2 Year+99.67%
3 Year+130.35%
Sector Average (1M)+2.27%
Sentinel Forensic Assessment
ALGORITHMIC RISK PROFILE • NON-ADVISORY

The structural architecture is currently robust. Capital resilience buffers in earnings quality remain well-maintained against forensic benchmarks. Systematic scans of operational margins and profitability metrics confirm the absence of material structural stress. Strategic vigilance is advised as structural decay is accelerating.

VIMTALABS • MARKET STRUCTURE

Stage 4 — Declining

The company is in a defensive phase. Sentiment and fundamentals are deteriorating under persistent downward pressure, indicating elevated risk levels.

Stage Transition Prob.0%
Trend QualityDeteriorating
Phase Progression
Phase Progression Score0%
Readiness LabelLow (Early Base Consolidation)
Probability of Advancing0%
CoinTree Momentum
Composite Z-Score-0.2451σ
Weakening momentum trend
Universe Rank
A cross-sectional rank of this stock's composite momentum score compared to all other tracked equities in the universe. A rank of #1 of 1035 means it has the strongest overall price momentum in the market.
#1520 of 2716
Top 55.96% in momentum strength
Timeframe Sparklines
1W+1.6%
1M+2.8%
6M-22.7%
Weinstein Indicators
150 DMA₹521.81
200 DMA₹572.26
150 DMA Slope-5.9439%Declining
Relative Strength-17.24%Lagging
Relative Turnover (RTR)0.2761
ParticipationWeak

PEER COMPARISON

Ranked comparison against sector peers

This company appears relatively stable compared to the Sector Mean (13).
VIMTALABSVIMTALABS
5 Risk
Sector %ile0th
Delta+5
Active Flags4
Accel+1
Earnings Quality

Stable

INDGNIndegene Limited
10 Risk
Sector %ile25th
Delta+5
Active Flags5
Accel+2
Earnings Quality

Stable

SUVENSUVEN
29 Risk
Sector %ile75th
Delta-5
Active Flags27
Accel+0
Balance Sheet Stress

Watch

SYNGENESyngene International Limited
35 Risk
Sector %ile100th
Delta0
Active Flags12
Accel+0
Earnings Quality

Watch

* Peer comparison is based on risk signals, not valuation or returns.

Risk Profiles

Solvency
10100th %ile
VS Sector Median (8.5)
Governance
10100th %ile
VS Sector Median (8.5)
Earnings Quality
6.868th %ile
VS Sector Median (8.5)
Balance Sheet Stress
10100th %ile
VS Sector Median (8.5)
Competitive Position
10100th %ile
VS Sector Median (8.5)
Growth Sustainability
10100th %ile
VS Sector Median (8.5)

Deterioration Timeline

2026

Operating Leverage Stress

2024

Inventory Stress

2024

Capex Efficiency Stress

Key Financials (INR Cr)

PeriodRevenueNet ProfitOCFDebt
FY2026416781473
FY202534867959
FY2024322416119
FY2023322488815